BEAM-304

N/A

Report date: 2026/05/18 20:02:07

Base Information

Drug NameBEAM-304

Drug Alias NameBEAM304BEAM-304

ClassificationCell and gene therapy > Gene therapy > LNPCell and gene therapy > Gene therapy > Gene editing > Base editingCell and gene therapy > Cell therapy > In vivo cell therapy

Mechanisms of ActionPhenylalanine hydroxylase modulators

TargetsPhenylalanine hydroxylase

Therapy Area/IndicationsPhenylketonurias

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBeam Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesBeam Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsPhenylketonurias

Inactive IndicationsN/A

Other Information

ATC CodeN/A